drugset / Trial / NCT07042126
Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective of the study was to evaluate the efficacy of 611 in Chinese Adolescents with moderate to severe atopic dermatitis.
Timeline
- Start
- 2025-08-05
- Primary completion
- 2026-06-30
- Completion
- 2027-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 611 | Monoclonal antibody | 300 mg | Subcutaneous |